Hem › Aplastisk anemi › Maryland
Kliniska studier för Aplastisk anemi i Maryland
10 studier för Aplastisk anemi söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1/2
Ålder 12 till 120 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06303193Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1/2
Ålder 4 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT03173937Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 2 till 99 · Alla kön · Uppdaterad 30 sep. 2026 · NCT05012111Cancer in Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
- National Cancer Institute - Shady Grove, Rockville
RekryterarObservationsstudieFriska volontärer välkomna
1 Day – 100 Years · Alla kön · Uppdaterad 30 sep. 2026 · NCT00027274Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06398457Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 4 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT01174108Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 4 till 75 · Alla kön · Uppdaterad 8 sep. 2026 · NCT03520647A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 3 till 99 · Alla kön · Uppdaterad 9 mars 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Johns Hopkins University, Baltimore
RekryterarFas 2
Ålder 3 till 75 · Alla kön · Uppdaterad 17 feb. 2026 · NCT06517641Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.